Valeant Plunges Anew On Report Of Possible Criminal Charges Against Former CEO, CFO |
November 01, 2016 | November 2016 Bond Updates |
Valeant Pharmaceuticals plunged on Monday afternoon after Bloomberg News reported the company's former CEO J. Michael Pearson and CFO Howard Schiller may face criminal charges for accounting fraud. |
View more at: http://www.forbes.com/sites/antoinegara/2016/10/31/valeant-plunges-anew-on-report-of-possible-criminal-charges-against-former-ceo-cfo/ |
Related News |
|